SXTC
China SXT Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.00M
P/E Ratio
—
EPS
$-57.15
Beta
1.75
52W High
$367.50
52W Low
$1.25
50-Day MA
$1.98
200-Day MA
$145.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the research, development, manufacture, marketing and sale of Traditional Chinese Medicine Tablets (TCMP) in China. The company is headquartered in Taizhou, China.
Fundamentals
| Revenue (TTM) | $1.54M |
| Gross Profit (TTM) | 334,400 |
| EBITDA | $-8.34M |
| Operating Margin | -1012.00% |
| Return on Equity | -50.30% |
| Return on Assets | -18.30% |
| Revenue/Share (TTM) | $3.90 |
| Book Value | $26.16 |
| Price-to-Book | 0.10 |
| Price-to-Sales (TTM) | 1.30 |
| EV/Revenue | 81.32 |
| EV/EBITDA | 7.08 |
| Quarterly Earnings Growth (YoY) | 42.60% |
| Quarterly Revenue Growth (YoY) | -24.50% |
| Shares Outstanding | 958,080 |
| Float | 702,050 |
| % Insiders | 9.24% |
| % Institutions | 0.07% |
Data last updated: 4/29/2026